Companies: 10,795·Total market cap: $144.5T
Boston Therapeutics, Inc.

Boston Therapeutics, Inc.

BTHEOTCHealthcare
$0.01
+$0.00(+0.00%)
Market Cap$0
P/E Ratio
52W High$0.0119
52W Low$0.0091
Overview

Boston Therapeutics, Inc.(BTHE)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BTHE · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2020-122019-122018-122017-122016-12
Revenue
Revenue$0.01M$0.02M$0.03M$0.03M$0.10M
Cost of Revenue$0.03M$0.03M$0.07M$0.00M$0.09M
Gross Profit($0.02M)($0.01M)($0.04M)$0.03M$0.00M
Gross Margin %(computed)-243.20%-65.40%-111.62%100.00%4.78%
Operating Expenses
R&D Expenses$0.18M$1.71M$0.18M$0.18M$0.08M
G&A Expenses$0.58M$0.98M$1.74M$1.09M$1.07M
Total Operating Expenses$0.76M$3.48M$2.00M$1.30M$1.27M
Operating Income($0.79M)($3.49M)($2.03M)($1.27M)($1.26M)
Operating Margin %(computed)
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.43M$0.34M$0.73M$1.66M$1.94M
Income Before Tax($0.91M)($3.69M)($3.60M)($1.58M)($3.73M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($0.91M)($3.69M)($3.60M)($1.58M)($3.74M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-0.01$-0.04$-0.04$-0.03$-0.09
Wtd Avg Shares111.13M102.50M102.50M51.47M43.54M
EBITDA($0.48M)($1.88M)($2.71M)$0.14M($1.72M)
EBITDA Margin %(computed)471.70%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Boston Therapeutics, Inc.

关于Boston Therapeutics, Inc.(BTHE)损益表

Boston Therapeutics, Inc.(BTHE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2020财年,BTHE实现营收$0.00B,毛利润($0.00B)(毛利率-243.20%),净利润($0.00B)(净利率-9724.54%)。

常见问题

BTHE · 4 问

Boston Therapeutics, Inc.(BTHE)2020财年营收为$0.00B,同比down42.8%。

BTHE revenueBTHE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09